Discover 4,544 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,544
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase2, Phase3, Recruiting
A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma
for
Lymphoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07030699
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
for
Low-grade Upper Tract Urothelial Carcinoma
Location: New York NY, Philadelphia PA, Jacksonville FL,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06668493
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Location: Saint John, Portland ME, Providence RI, Worcester MA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06679101
Phase3, Recruiting
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
for
Heart Failure
Location: New York NY
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT06118983
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
for
Alzheimer's Disease
Location: Valley Stream NY, Staten Island NY, Morehead City NC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011745
Phase3, Recruiting
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
for
Pancreatic Cancer, Pancreatic Adenocarcinoma,
Location: The Bronx NY, New York NY, Montreal, Cooperstown NY,
Sponsor: Alpha Tau Medical LTD.
Sex: All
Age: 18 - 70+
Code: NCT06698458
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: New Hyde Park NY, Long Island City NY, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07018323
Phase2, Recruiting
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
for
Prostate Cancer
Location: New Haven CT, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male
Age: 18+
Code: NCT06457919
Phase1, Phase2, Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Boston MA, Lebanon NH, New Hyde Park NY, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06997029
Phase1, Recruiting
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
for
Hemophilia A, Hemophilia B
Location: New York NY, Philadelphia PA, Tampa FL,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT05568719
Phase3, Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
for
Chronic Rhinosinusitis Without Nasal Polyps
Location: Towson MD, Rochester NY, North Charleston SC,
Sponsor: Optinose US Inc.
Sex: All
Age: 12 - 17
Code: NCT06850805
Phase3, Recruiting
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
for
Mature B-cell Malignancies
Location: Westbury NY, Plantation FL
Sponsor: InnoCare Pharma Inc.
Sex: All
Age: 18+
Code: NCT06351527
Phase1, Recruiting
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
for
Blood Cancer, Lymphoma, Leukemia, Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07052916
Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
for
Renal Cell Carcinoma
Location: Mineola NY, New York NY, Durham NC, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07049926
Phase1, Phase2, Recruiting
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
for
Ovarian Cancer Recurrent, Ovarian Cancer,
Location: Buffalo NY, Detroit MI, Minneapolis MN, Houston TX